Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 18 January, 2005 and appeared in  Issue 243

Duration And Severity Of Obesity Limits Cardiovascular Benefits Of Weight Reduct

Weight loss was associated with significant reduction in risk of diabetes but not CVD.
Advertisement
So S Goya Wannamethee, A. Gerald Shaper and Mary Walker of the Department of Primary Care and Population Science, Royal Free and University College Medical School, London, UK followed British men up for 20 years. These men aged 40–59 years had no diagnosis of CVD or diabetes.

During the 20 year follow up there were 1989 major CVD events and 449 incident cases of diabetes in the 7176 men.

Risk of major CVD and diabetes increased significantly with increasing overweight and obesity. During the 15 year follow up, weight gain was associated with increased risk of CVD and diabetes.

Weight loss was associated with lower risk of diabetes than the stable group irrespective of initial weight. No significant cardiovascular benefit was seen for weight loss in any men, except possibly in considerably overweight (BMI 27.5–29.9 kg/m2) younger middle aged men (RR = 0.42; 95% CI 0.22 to 0.81).

Long term risk of CVD and diabetes increased significantly with increasing overweight and obesity. Weight loss was associated with significant reduction in risk of diabetes but not CVD, except possibly in considerably overweight younger men.

Duration and severity of obesity seem to limit the cardiovascular benefits of weight reduction in older men.

Journal of Epidemiology and Community Health 2005;59:134-139


===============================

FACT:
The Alcohol, Tobacco, Tax and Trade Bureau (TTB) has determined that the standard serving size for wine is 5-ounces, but most companies that offer low carb wines use 3.5 ounces as a serving.
The Low Carb Bartender, Adams Media,

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 18 January, 2005 and appeared in  Issue 243

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:



Search Articles On Diabetes In Control